parenteral nutrition-associated liver disease

Analysis of the relative impact of parenteral nutrition on liver dysfunction in critically ill patients, characterizing the presence of pre-existing liver disturbances, acute heart failure, sepsis, daily parenteral nutrition volume, and commonly used hepatotoxic drugs in adult ICU patients, together with daily aspartate aminotransferase, alanine aminotransferase, gamma-glutamyltransferase, alkalic phosphatase, total bilirubin, and INR values.

The purpose of this study was to investigate the efficacy of early parenteral nutrition in congenital
diaphragmatic hernia neonates.

Evaluation of the risk factors and liver function testing as predictors of parenteral nutrition-associated cholestasis in premature infants with intestinal perforation.

AIM: to evaluate the association between use of total parenteral nutrition exclusively and changes in hepatic profile, and investigation between age, hypertriglyceridemia, and hypercholesterolemia, and the occurrence of liver dysfunction.

Examination of outcomes in children with IF-associated liver disease who have required long-term parenteral nutrition and Fish oil lipid emulsion therapy.